STRATEGY FOR 18th JANUARY
EQUITY UPDATE
MARKET TREND - NIFTY(SPOT) - Negative(from 17940), stop - 18300
BANKNIFTY(SPOT) - Negative(from 42240), stop - 43300.
INSTITUTIONAL ACTIVITY- Fii - Net buy - 211 crores.
Dii - Net buy - 90 crores.
GLOBAL MARKETS- US markets trading negative at the time of writing.
RESULTS TODAY - Indusindbk, Ofss, Persistent.
RESULTS TOMORROW - Asianpaint, Aubank, Canfinhome, Happiestmind,
Havells, Hindunilvr, Hindzinc, Indiamart, Ltts,
Mphasis, Polycab, Pvr.
INVESTMENT IDEAS
Genus power - 67. Philipcarb(10/01/2022) - 244, Equitasbnk - 53,
Ajantpharma(18/04/2022) - 1740, Zyduswellness- 1630, Ircon- 16/08/2022)- 41,
SOTL(14/12/2022)- 332, Texrail(14/12/2022)- 58, Sail-(09/01/2022)- 88.
SHORT TERM
Lici- buy 723, target - 795. stop - 654
TECHNICAL
MOMENTUM
POSITIONAL
Recltd- Buy(02/01/2023) - 118.20, target 1 hit- 126, target 2 -132, stop - 119.
Redington - Buy above - 190.5, target - 212, stop - 176.
Recltd- Buy(02/01/2023) - 118.20, target 1 hit- 126, target 2 -132, stop - 119.
Redington - Buy above - 190.5, target - 212, stop - 176.
COMMODITY
MCX
SILVERMIC(feb 28)- Buy(16/01/2023) - 69500, target - 71800, stop 67500.
CURRENCY
JPYINR(JAN 27)- Buy(16/01/2023)- 63.70, target 65.30, stop - 62.10.
EURINR (JAN27)- Buy(17/01/2023) - 88.60, target - 89.60, stop - 87.80.
GBPINR (JAN 27)- Buy above - 100.45, target - 102.45, stop - 99.10.
DISCLAIMER- This blog is just my trading ideas or how i follow the market. This blog is merely a device that can help you to think and consider, but you are 100% responsible for any actions you take by reading this blog.)
JPYINR(JAN 27)- Buy(16/01/2023)- 63.70, target 65.30, stop - 62.10.
EURINR (JAN27)- Buy(17/01/2023) - 88.60, target - 89.60, stop - 87.80.
GBPINR (JAN 27)- Buy above - 100.45, target - 102.45, stop - 99.10.
DISCLAIMER- This blog is just my trading ideas or how i follow the market. This blog is merely a device that can help you to think and consider, but you are 100% responsible for any actions you take by reading this blog.)
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home